Evidence mapPaperPMID 41858581Full record

ReviewInternational journal of nanomedicine2026

Mechanism-Inspired Biomaterials and Regenerative Therapies for Radiation-Induced Skin Injury.

Ying Zhou, Xuewen Zhang, Xing Shen, Shuang Xing, Yong Yuan, Weiming Tian, Zuyin Yu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying ZhouSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, People's Republic of China.
Xuewen ZhangDepartment of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Xing ShenDepartment of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Shuang XingDepartment of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Yong YuanDepartment of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Weiming TianSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, People's Republic of China.
Zuyin YuDepartment of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation-induced skin injury (RISI) represents the most common complication of cancer radiotherapy, severely impairing patient health and treatment adherence. Conventional therapies show limited benefits due to the complex pathological mechanisms of RISI, creating an urgent demand for more effective approaches. Emerging biomaterials and regenerative therapies offer new opportunities for intervention. This review first outlines the key mechanisms of RISI and then highlights the mechanism-driven biomaterial design, with particular focus on the rational selection of active ingredients and advanced delivery systems. We also examine regenerative therapies such as stem cell therapy and mitochondrial transplantation, emphasizing their potential to restore function at cellular or organelle levels. Finally, the major challenges and future directions of these therapeutic strategies in RISI treatment are discussed.

Indexed as

Biocompatible MaterialsRadiation InjuriesRadiodermatitisRegenerative MedicineSkinAnimalsHumansBiocompatible Materialsbiomaterialsradiation-induced skin injuryregenerative therapieswound healing

Identifiers

PMID41858581
PMCPMC12998469

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.